Nov 14 (Reuters) - BIOTEST AG  BIOG.DE : 
    * DGAP-NEWS: BIOTEST AG: BIOTEST GENERATES REVENUES OF EUR 377.8 MILLION IN THE FIRST NINE 
MONTHS 
2017 
    * 9M REVENUE 377.8 MILLION EUR 
    * PAUL-EHRLICH INSTITUTE APPROVES PHASE III TRIAL IN INDICATION OF ACQUIRED FIBRINOGEN 
DEFICIENCY 
    * EBIT OF CONTINUING OPERATIONS TOTALED EUR -15.7 MILLION IN FIRST THREE QUARTERS OF 2017 
AFTER 
EUR 47.5 MILLION 
    * 9-MONTH EARNINGS AFTER TAXES OF CONTINUING OPERATIONS OF EUR -22.7 MILLION VERSUS EUR 
13.3 
MILLION YEAR AGO 
 
Source text for Eikon:  ID:nEQc49CrHa  
Further company coverage:  BIOG.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))